Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents

Joe Sasadeusz; Andrew Grigg; Peter D. Hughes; Seng Lee Lim; Michaela Lucas; Geoff McColl; Sue Anne McLachlan; Marion G. Peters; Nicholas Shackel; Monica Slavin; Vijaya Sundararajan; Alexander Thompson; Joseph Doyle; James Rickard; Peter De Cruz; Robert G. Gish; Kumar Visvanathan

doi:10.1016/j.cld.2019.04.012

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents

Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish, Kumar Visvanathan

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	521-534
Number of pages	14
Journal	Clinics in Liver Disease
Volume	23
Issue number	3
DOIs	https://doi.org/10.1016/j.cld.2019.04.012
State	Published - Aug 2019
Externally published	Yes

ASJC Scopus Subject Areas

Hepatology

Keywords

Anti-CD20
Direct-acting antivirals
Hepatitis B
Inflammatory bowel diseases
Reactivation
Rheumatoid arthritis

Access to Document

10.1016/j.cld.2019.04.012

OpenUrl availability

Full text

Cite this

Sasadeusz, J., Grigg, A., Hughes, P. D., Lee Lim, S., Lucas, M., McColl, G., McLachlan, S. A., Peters, M. G., Shackel, N., Slavin, M., Sundararajan, V., Thompson, A., Doyle, J., Rickard, J., De Cruz, P., Gish, R. G., & Visvanathan, K. (2019). Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents. Clinics in Liver Disease, 23(3), 521-534. https://doi.org/10.1016/j.cld.2019.04.012

Sasadeusz, J, Grigg, A, Hughes, PD, Lee Lim, S, Lucas, M, McColl, G, McLachlan, SA, Peters, MG, Shackel, N, Slavin, M, Sundararajan, V, Thompson, A, Doyle, J, Rickard, J, De Cruz, P, Gish, RG & Visvanathan, K 2019, 'Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents', Clinics in Liver Disease, vol. 23, no. 3, pp. 521-534. https://doi.org/10.1016/j.cld.2019.04.012

@article{869e7d1c2a0e41f9affd7675f36ae2ea,

title = "Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents",

keywords = "Anti-CD20, Direct-acting antivirals, Hepatitis B, Inflammatory bowel diseases, Reactivation, Rheumatoid arthritis",

author = "Joe Sasadeusz and Andrew Grigg and Hughes, {Peter D.} and {Lee Lim}, Seng and Michaela Lucas and Geoff McColl and McLachlan, {Sue Anne} and Peters, {Marion G.} and Nicholas Shackel and Monica Slavin and Vijaya Sundararajan and Alexander Thompson and Joseph Doyle and James Rickard and {De Cruz}, Peter and Gish, {Robert G.} and Kumar Visvanathan",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = aug,

doi = "10.1016/j.cld.2019.04.012",

language = "English",

volume = "23",

pages = "521--534",

journal = "Clinics in Liver Disease",

issn = "1089-3261",

number = "3",

}

TY - JOUR

T1 - Screening and Prophylaxis to Prevent Hepatitis B Reactivation

T2 - Other Populations and Newer Agents

AU - Sasadeusz, Joe

AU - Grigg, Andrew

AU - Hughes, Peter D.

AU - Lee Lim, Seng

AU - Lucas, Michaela

AU - McColl, Geoff

AU - McLachlan, Sue Anne

AU - Peters, Marion G.

AU - Shackel, Nicholas

AU - Slavin, Monica

AU - Sundararajan, Vijaya

AU - Thompson, Alexander

AU - Doyle, Joseph

AU - Rickard, James

AU - De Cruz, Peter

AU - Gish, Robert G.

AU - Visvanathan, Kumar

PY - 2019/8

Y1 - 2019/8

KW - Anti-CD20

KW - Direct-acting antivirals

KW - Hepatitis B

KW - Inflammatory bowel diseases

KW - Reactivation

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85066490320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066490320&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2019.04.012

DO - 10.1016/j.cld.2019.04.012

M3 - Review article

C2 - 31266625

AN - SCOPUS:85066490320

SN - 1089-3261

VL - 23

SP - 521

EP - 534

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

IS - 3

ER -

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this